Cart
Shopping cart

Mariana Tesarova

Zinzinokunde

Velkommen! Jeg har haft gode resultater med mine produkter og jeg tror, at du også vil elske dem. Lad mig høre, hvad du tænker!

Press releases - 5. februar 2024 15:00 CET

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

Zinzino group revenue increased with a total of 15%, compared with the previous year.

The revenue in January for Zinzino's sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma's external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK 24-Jan 23-Jan Change
The Nordics 22.6 23.4 -3%
Central Europe 41,0 28.5 44%
East Europe 31.8 32.8 -3%
South & West Europe 21.8 15.9 37%
The Baltics 8,0 7.4 8%
North America 10.1 6.3 60%
Asia-Pacific 3.9 4.6 -15%
Africa 1,0 1.4 -29%
Zinzino 140.2 120.3 17%
Faun Pharma 8.1 9.1 -11%
Zinzino Group 148.3 129.4 15%

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)